文献速递泌尿生殖MR

混合多维MRI测量前列腺组织成分的组织学验证:与病理学家测量结果的一致性

Histological validation of prostate tissue composition measurement using hybrid multi-dimensional MRI: agreement with pathologists' measures.
PubMed 文献 · Abdom Radiol (NY) · 2021-12-08

前瞻性纳入36例活检确诊前列腺癌患者,根治性切除术前行3T混合多维MRI(HM-MRI),以三位泌尿病理学家对全标本病理切片的共识判读为参考标准,评估HM-MRI测量上皮和管腔体积分数的一致性。结果显示HM-MRI与病理共识的一致性(TDI0.9上皮18.8%、管腔22.4%)达到预设标准(95%单侧上限<30%),且与病理学家之间的一致性(上皮22.3%、管腔24.2%)相当。

要点

  • HM-MRI测量上皮和管腔体积分数与病理共识的一致性达到预设标准(95%单侧上限<30%)。
  • HM-MRI与病理共识的一致性水平和病理学家之间的一致性相当。
  • HM-MRI鉴别癌与良性组织的上皮AUC为0.87、管腔AUC为0.85。

核心结论

  • HM-MRI测量前列腺组织成分与病理学家共识的一致性达到预设标准,且与病理学家之间的一致性相当。

研究设计与样本

  • 前瞻性研究纳入36例活检确诊前列腺癌患者,根治性切除术前行3T MRI;HM-MRI采用回波时间57、70、150、200 ms与b值0、150、750、1500 s/mm2全组合采集,用三室信号模型拟合生成基质、上皮、管腔体积;参考标准为三位泌尿病理学家独立及共识判读全标本病理切片,对应MRI的感兴趣区共165个(64个前列腺癌、101个良性组织)。

诊断标准与关键数值

  • 预设可接受一致性标准为TDI0.9的95%单侧置信上限小于30%;HM-MRI与三位病理学家共识比较,上皮和管腔的TDI0.9分别为18.8%和22.4%,95%置信上限分别为20.6%和24.2%;病理学家之间的一致性上皮为22.3%、管腔为24.2%;基于上皮体积鉴别癌与良性组织的ROC曲线下面积HM-MRI为0.87、病理学家为0.97,基于管腔体积HM-MRI为0.85、病理学家为0.77。

局限性

  • 基于初始结果显示病理学家之间典型变异TDI0.9=25%,研究预设可接受一致性标准为TDI0.9的95%单侧置信上限小于30%。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To validate prostate tissue composition measured using hybrid multi-dimensional MRI (HM-MRI) by comparing with reference standard (ground truth) results from pathologists' interpretation of clinical histopathology slides following whole mount prostatectomy.

MATERIALS AND METHODS: 36 prospective participants with biopsy-confirmed prostate cancer underwent 3 T MRI prior to radical prostatectomy. Axial HM-MRI was acquired with all combinations of echo times of 57, 70, 150, 200 ms and b-values of 0, 150, 750, 1500 s/mm2 and data were fitted using a 3-compartment signal model using custom software to generate volumes for each tissue component (stroma, epithelium, lumen). Three experienced genitourinary pathologists independently as well as in consensus reviewed each histology image and provide an estimate of percentage of epithelium and lumen for regions-of-interest corresponding to MRI (n = 165; 64 prostate cancers and 101 benign tissue). Agreement statistics using total deviation index (TDI0.9) was performed for tissue composition measured using HM-MRI and reference standard results from pathologists' consensus.

RESULTS: Based on the initial results showing typical variation among pathologists TDI0.9 = 25%, we determined we will declare acceptable agreement if the 95% one-sided upper confident limit of TDI0.9 is less than 30%. The results of tissue composition measurement from HM-MRI compared to ground truth results from the consensus of 3 pathologists, reveal that ninety percent of absolute paired differences (TDI0.9) were within 18.8% and 22.4% in measuring epithelium and lumen, respectively. We are 95% confident that 90% of absolute paired differences were within 20.6% and 24.2% in measuring epithelium and lumen, respectively. These were less than our criterion of 30% and inter-pathologists' agreement (22.3% for epithelium and 24.2% for lumen) and therefore we accept the agreement performance of HM-MRI. The results revealed excellent area under the ROC curve for differentiating cancer from benign tissue based on epithelium (HM-MRI: 0.87, pathologists: 0.97) and lumen volume (HM-MRI: 0.85, pathologists: 0.77).

CONCLUSION: The agreement in tissue composition measurement using hybrid multidimensional MRI and consensus of pathologists is on par with the inter-raters (pathologists) agreement.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Chatterjee, Antic, Gallan, et al. Histological validation of prostate tissue composition measurement using hybrid multi-dimensional MRI: agreement with pathologists' measures. Abdom Radiol (NY). 2021. PMID: 34878579. doi:10.1007/s00261-021-03371-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。